Postpartum Low Mood: When to See a Doctor
At a glance
- Condition / Baby blues vs. Postpartum depression (PPD)
- How common is PPD / Affects up to 1 in 5 women after birth
- Baby blues timing / Days 2-5 postpartum, resolves by day 14
- PPD onset window / Any time in the first 12 months, most often weeks 2-8
- Screening tool / Edinburgh Postnatal Depression Scale (EPDS), score <10 normal
- Life-stage note / Risk is elevated in perimenopause after late pregnancy (age 35+)
- First-line treatment options / Therapy (CBT), SSRIs, or both
- Emergency signal / Thoughts of harming yourself or your baby: call 988 or go to the ER now
Why You Feel This Way: The Hormone Crash Behind Postpartum Low Mood
Low mood after birth is not a personality flaw or a sign that you are failing as a mother. It has a clear biological trigger. During pregnancy, estrogen and progesterone rise to levels roughly 100 times higher than pre-pregnancy baseline. Within 24 to 72 hours of delivering the placenta, both hormones plummet back to their follicular-phase range. That drop is faster and steeper than anything that happens during the menstrual cycle or even the menopause transition.
What the hormones are actually doing to your brain
Progesterone metabolizes into allopregnanolone, a neurosteroid that acts on GABA receptors much like a natural sedative. When allopregnanolone levels crash postpartum, the brain's inhibitory tone drops sharply. For women whose GABA receptors are more sensitive to this shift, that translates into anxiety, irritability, and low mood. This receptor sensitivity is the same mechanism targeted by brexanolone (Zulresso), the first IV medication approved specifically for postpartum depression.
Prolactin, which surges if you are breastfeeding, has its own mood effects. High prolactin suppresses estrogen, which can prolong the low-estrogen state and, in some women, worsen dysphoria. This is one reason breastfeeding women sometimes report mood changes that continue well past the two-week baby-blues window.
The role of thyroid changes
Postpartum thyroiditis affects roughly 5 to 10 percent of women in the first year after delivery. The initial hyperthyroid phase (weeks 1 to 4) can cause anxiety and emotional lability. The hypothyroid phase (months 2 to 6) can look almost identical to postpartum depression: fatigue, low mood, cognitive fog, and low motivation. Every woman presenting with postpartum low mood should have TSH checked. Missing a thyroid cause means treating the wrong problem.
Baby Blues vs. Postpartum Depression: The Clinical Distinction That Changes Everything
These are not two points on a spectrum. They are distinct clinical entities with different durations, intensities, and treatment needs.
Baby blues
Baby blues affect up to 80 percent of women after delivery. Symptoms peak on days 3 to 5, typically coinciding with milk coming in and the steepest hormone drop. You may cry without a clear reason, feel irritable one hour and fine the next, and feel a strange emotional detachment. Baby blues do not prevent you from functioning. You can still care for your baby, sleep when the baby sleeps, and feel moments of genuine joy.
Baby blues resolve on their own by day 14. No medication is needed. Practical support, sleep where possible, and reassurance are the standard approach endorsed by ACOG Practice Bulletin No. 92.
Postpartum depression
Postpartum depression is different in degree and duration. Symptoms persist beyond two weeks, interfere with daily function, and may include:
- Persistent sadness or emotional numbness lasting most of the day
- Loss of interest in your baby or in things you previously enjoyed
- Difficulty bonding, sometimes accompanied by guilt about that difficulty
- Sleep disruption beyond normal newborn-related exhaustion
- Appetite changes in either direction
- Concentration problems that feel different from normal new-parent fog
- Feelings of worthlessness or excessive guilt
- Recurrent thoughts of death or self-harm
ACOG defines PPD as a major depressive episode beginning in pregnancy or within four weeks of delivery by strict DSM-5 criteria, though clinically most practitioners and the DSM-5-TR recognize onset up to 12 months postpartum. Approximately 1 in 5 women will meet criteria for PPD at some point in that first year.
Who Is at Higher Risk: A Life-Stage and Condition Breakdown
Risk is not evenly distributed. Certain hormonal contexts and life circumstances raise the probability significantly.
Reproductive years and first pregnancies
Women with a personal history of depression or anxiety carry a two- to threefold higher risk of PPD. Women with premenstrual dysphoric disorder (PMDD) are particularly vulnerable because their brains are already shown to be more reactive to progesterone and allopregnanolone fluctuations, which means the postpartum hormone drop hits harder. One prospective cohort found that women with PMDD had a 66 percent rate of postpartum depressive symptoms compared to 26 percent in women without PMDD.
PCOS
Women with polycystic ovary syndrome (PCOS) have higher baseline rates of depression and anxiety throughout their reproductive years. The hormonal and inflammatory environment of PCOS may make the postpartum period particularly destabilizing. Screening for PPD in women with known PCOS deserves extra attention at every postpartum visit.
Pregnancy after 35 (the "advanced maternal age" window)
Women who deliver after 35 are approaching perimenopause, and their ovarian reserve and hormone fluctuation patterns are already shifting. Some evidence suggests that the postpartum estrogen withdrawal may be more pronounced in this group, though large-scale data are still limited. If you are 38, feel persistently low after delivery, and your provider dismisses it as normal, asking for an EPDS screen and a TSH is entirely reasonable.
Previous pregnancy loss or infertility
Women who conceived through assisted reproduction or who experienced prior pregnancy loss carry a specific grief-and-vigilance burden that can compound hormonal vulnerability. The ASRM notes that psychological distress in women with infertility history can persist into the postpartum period and warrants proactive screening.
Social risk factors
Lack of partner or social support, financial stress, intimate partner violence, unplanned pregnancy, and poor sleep (beyond normal newborn disruption) are all independent risk factors. These are not character weaknesses; they are real biological stressors that alter cortisol, serotonin, and inflammatory markers in ways that lower mood.
When to See a Doctor: A Concrete Timeline
This is the section most articles get vague about. Here is a specific, actionable framework.
Call your provider the same day if:
- Low mood has lasted more than two weeks without any improvement
- You are unable to care for yourself or your baby
- You feel no emotional connection to your baby and that absence has lasted more than a few days
- You are having intrusive thoughts about harming yourself or your baby, even if you would never act on them
- You are experiencing racing thoughts, very little need for sleep, and feel unusually elevated or grandiose (this may be postpartum mania or bipolar disorder, which requires urgent evaluation)
Go to the emergency room or call 988 immediately if:
- You have a specific plan to harm yourself
- You are hearing or seeing things that others cannot
- You feel a compulsion to harm your baby
Book a routine appointment within the week if:
- Baby blues have improved but you still feel "not yourself" after two weeks
- You feel anxious more than you feel sad
- You are managing to function but feel like you are operating on autopilot with no pleasure
Do not wait for your standard six-week postpartum checkup if any of these apply. ACOG recommends that postpartum care be an ongoing process with contact in the first three weeks, not a single six-week visit.
How Postpartum Low Mood Is Diagnosed
Your provider will likely use a validated screening tool alongside a clinical interview.
The Edinburgh Postnatal Depression Scale (EPDS)
The EPDS is a 10-item self-report questionnaire validated in dozens of languages and health systems. A score of 10 or higher suggests possible depression; a score of 13 or higher has high sensitivity for major depressive disorder. Item 10 specifically screens for thoughts of self-harm and requires immediate follow-up regardless of total score. ACOG recommends screening all women at least once with a validated tool in the postpartum period, and ideally at the first postpartum contact, at six weeks, and at the well-baby visits through 6 months.
Lab work your provider should consider
A full thyroid panel (TSH, free T4) rules out postpartum thyroiditis. A complete blood count checks for iron-deficiency anemia, which causes fatigue and cognitive changes that mimic depression. Vitamin D deficiency is also worth checking; low vitamin D has been associated with increased PPD risk in several observational studies, though causality is not confirmed.
Ruling out postpartum anxiety and postpartum OCD
Up to 15 percent of women experience postpartum anxiety as their primary presentation rather than depression. Postpartum OCD, characterized by intrusive and distressing thoughts (not intent) about harm to the baby, is frequently misunderstood and undertreated. Both respond to SSRIs and therapy but the clinical picture looks different from classic PPD, so accurate diagnosis matters.
Treatment Options for Postpartum Low Mood
Treatment depends on severity, your breastfeeding status, your preferences, and whether an underlying medical cause has been found.
Psychotherapy
Cognitive behavioral therapy (CBT) and interpersonal therapy (IPT) both have strong trial evidence for PPD. For mild to moderate PPD, therapy alone may be sufficient. Access is a real barrier: waitlists can be long and postpartum women are time-poor. Telehealth CBT programs have shown comparable outcomes to in-person delivery in several trials, which matters for a population that may not be able to leave the house easily.
SSRIs and SNRIs
For moderate to severe PPD, medication is often recommended alongside therapy. Sertraline and paroxetine are the most studied SSRIs in postpartum women and during breastfeeding. Sertraline transfers into breast milk at low levels, with infant serum levels typically undetectable or below the limit of quantification. LactMed, the NIH database for drug and lactation information, is a reliable real-time resource for checking any medication you are prescribed while breastfeeding.
Medication usually takes four to six weeks to reach full effect. If you are not feeling improvement by week six at an adequate dose, your provider should reassess rather than simply wait longer.
Brexanolone (Zulresso) and zuranolone (Zurzuvae)
Brexanolone was the first medication specifically approved for PPD by the FDA in 2019. It is a synthetic form of allopregnanolone administered as a 60-hour IV infusion in a certified healthcare setting. Response is rapid (within 24 to 48 hours) in clinical trials. Its accessibility is limited by cost and the requirement for inpatient monitoring.
Zuranolone (Zurzuvae) received FDA approval in August 2023 as an oral, 14-day course with demonstrated efficacy in the SKYLARK trial. In the SKYLARK study, women taking 50 mg zuranolone daily for 14 days showed significantly greater reduction in the Hamilton Rating Scale for Depression compared to placebo as early as day 3. This is a meaningful advance for women who cannot access or afford IV therapy. Zuranolone is not recommended during breastfeeding based on current data; your provider will discuss whether pausing breastfeeding or choosing an alternative makes sense for your situation.
Non-pharmacological supports that have actual evidence
Bright light therapy (10,000 lux for 30 minutes each morning) has randomized trial support for perinatal depression. Exercise, specifically 30 to 45 minutes of moderate aerobic activity at least three days per week, has demonstrated antidepressant effects in the postpartum period. Neither is a replacement for treatment of moderate to severe PPD, but both are useful additions.
Social support is not just a nice-to-have. Structured social support interventions (mother groups, home visitor programs) have reduced PPD severity in randomized controlled trials.
Postpartum Low Mood Across the Full Reproductive Lifespan
After pregnancy loss, stillbirth, and TFMR
Grief after any pregnancy loss can produce a clinical picture identical to PPD, including the same hormonal crash from the sudden end of pregnancy hormones. Women who experience stillbirth or termination for medical reasons are often excluded from postpartum support systems, yet their biological and psychological needs are the same. If you are in this situation, you deserve the same screening and care.
Postpartum period after subsequent pregnancies
A history of PPD is the single strongest predictor of PPD in a future pregnancy. Women with previous PPD have a recurrence risk of approximately 40 to 50 percent with subsequent deliveries. Planning ahead, including preconception discussion of prophylactic treatment or early intervention, is supported by evidence and should be part of your pre-pregnancy counseling if PPD is in your history.
The perimenopausal postpartum overlap
Women who deliver in their late 30s or early 40s may experience postpartum low mood that blends with early perimenopause. The vasomotor and mood symptoms of perimenopause can begin years before the final menstrual period. If your low mood and sleep disruption do not resolve after the baby is sleeping well and breastfeeding has ended, asking for an FSH and estradiol level is worth considering at that point, particularly if you are 40 or older.
Who This Is Right for and Who Needs More Urgent Care
This article addresses the full range of postpartum low mood from baby blues through PPD. But some presentations fall outside what routine outpatient postpartum care can handle safely.
Outpatient care is appropriate if you have mild to moderate symptoms, you are not at risk of harming yourself or your baby, you have some social support, and you can attend appointments or access telehealth.
You need same-day or urgent evaluation if you have thoughts of suicide or self-harm, you are experiencing psychotic symptoms (seeing or hearing things), your mood is shifting between extreme highs and lows (possible bipolar disorder), or you are unable to care for yourself or your baby at all.
Postpartum psychosis is rare, affecting roughly 1 to 2 in 1,000 women, but it is a psychiatric emergency. Onset is typically within the first two weeks postpartum. Symptoms include confusion, hallucinations, paranoia, and rapid mood swings. If anyone in your household notices these signs in you, the right response is the emergency room, not a call to your OB's after-hours line.
Frequently asked questions
›What causes postpartum low mood?
›How is postpartum low mood diagnosed?
›When should I worry about postpartum low mood?
›Is postpartum low mood the same as postpartum depression?
›Can postpartum depression start months after birth?
›Is it safe to take antidepressants while breastfeeding?
›What is the Edinburgh Postnatal Depression Scale?
›Does postpartum thyroiditis cause low mood?
›What is postpartum psychosis and how is it different from postpartum depression?
›Will I get postpartum depression with my next pregnancy?
›Can postpartum low mood affect my ability to breastfeed?
References
- Schiller CE, Meltzer-Brody S, Rubinow DR. The role of reproductive hormones in postpartum depression. CNS Spectr. 2015;20(1):48-59.
- Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21(10):1081-1125.
- Henshaw C. Mood disturbance in the early puerperium: a review. Arch Womens Ment Health. 2003;6(Suppl 2):S33-42.
- Wisner KL, Sit DK, McShea MC, et al. Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings. JAMA Psychiatry. 2013;70(5):490-498.
- Haga SM, Drozd F, Slinning K, Aas B. The Edinburgh Postnatal Depression Scale. Tidsskr Nor Laegeforen. 2012;132(9):1069.
- Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression: development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987;150:782-786.
- ACOG Committee Opinion No. 736: Optimizing postpartum care. Obstet Gynecol. 2018;131(5):e140-e150.
- ACOG Practice Bulletin No. 92: Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol. 2008;111(4):1001-1020.
- ACOG. Postpartum depression. Womenshealth.acog.org.
- Pearlstein T, Howard M, Salisbury A, Zlotnick C. Postpartum depression. Am J Obstet Gynecol. 2009;200(4):357-364.
- Brexanolone injection prescribing information. FDA. 2019.
- Zuranolone (Zurzuvae) prescribing information. FDA. 2023.
- Clayton AH, Lasser R, Parikh SV, et al. Zuranolone for the treatment of postpartum depression: SKYLARK trial. JAMA Psychiatry. 2023;80(9):894-902.
- Parry BL, Curran ML, Stuenkel CA, et al. Can critically timed sleep deprivation be useful in pregnancy and postpartum depression? J Affect Disord. 2000;60(3):201-212.
- Dennis CL, Dowswell T. Psychosocial and psychological interventions for preventing postpartum depression. Cochrane Database Syst Rev. 2013;(2):CD001134.
- Wisner KL, Peindl KS, Gigliotti T, Hanusa BH. Obsessions and compulsions in women with postpartum depression. J Clin Psychiatry. 1999;60(3):176-180.
- Doucet S, Jones I, Letourneau N, Dennis CL, Blackmore ER. Interventions for the prevention and treatment of postpartum psychosis. Arch Womens Ment Health. 2011;14(2):89-98.
- Bloch M, Schmidt PH, Danaceau M, Murphy J, Nieman L, Rubinow DR. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry. 2000;157(6):924-930.
- Gunderson EP, Lewis CE, Lin Y, et al. Lactation duration and progression to diabetes in women across the childbearing years. JAMA Intern Med. 2018;178(3):328-337.
- Seeman MV. Women's Issues in Schizophrenia: postpartum and reproductive health. Fertil Steril. 2021;116(2):314-322.
- LactMed: Drugs and Lactation Database. National Library of Medicine. Sertraline entry.
- Weissman AM, Levy BT, Hartz AJ, et al. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry. 2004;161(6):1066-1078.